...
首页> 外文期刊>Clinical Infectious Diseases >Interpreting Assays for the Detection of Streptococcus pneumoniae
【24h】

Interpreting Assays for the Detection of Streptococcus pneumoniae

机译:肺炎链球菌检测的解释方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Streptococcus pneumoniae is both an aggressive pathogen and a normal part of the human respiratory microbiome. Clinicians and microbiologists have struggled to develop tests that can identify pneumococcal respiratory infection and accurately distinguish colonization from invasive disease. Molecular methods hold the promise of an improved ability to rapidly detect microorganisms in respiratory secretions and to make an accurate diagnosis; however, interpretation of diagnostic testing for S. pneumoniae remains problematic. Molecular assays, such as those targeting the pneumolysin gene, may cross-react with other streptococcal species, confounding detection and quantification. Assays that target the autolysin gene appear to be more specific. Even when accurately identified, however, the significance of S. pneumoniae DNA detected in clinical samples is difficult to determine. Here we will discuss the challenges faced in the interpretation of molecular testing for S. pneumoniae, and some strategies that might be used to improve our ability to diagnose pneumococcal respiratory infection.
机译:肺炎链球菌既是攻击性病原体,也是人类呼吸微生物组的正常部分。临床医生和微生物学家一直在努力开发能够识别肺炎球菌呼吸道感染并准确区分定植与侵袭性疾病的检测方法。分子方法有望提高快速检测呼吸道分泌物中微生物并进行准确诊断的能力。然而,对肺炎链球菌的诊断测试的解释仍然存在问题。诸如针对肺炎球菌溶血素基因的分子检测可能会与其他链球菌物种发生交叉反应,从而混淆检测和定量。靶向自溶素基因的测定似乎更具特异性。然而,即使准确地鉴定出,临床样品中检测到的肺炎链球菌DNA的重要性也难以确定。在这里,我们将讨论在肺炎链球菌分子检测的解释中面临的挑战,以及一些可用于提高我们诊断肺炎球菌呼吸道感染能力的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号